Melanocytes, melanocyte stem cells, and melanoma stem cells

Clinics in Dermatology

Volumn 31, Issue 2, 2013, Pages 166-178

  Lang, Deborah ^a   Mascarenhas, Joseph B ^a   Shea, Christopher R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; DACARBAZINE; DOXORUBICIN; RITUXIMAB;

ADULT STEM CELL; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; HUMAN; MELANOCYTE; MELANOCYTE STEM CELL; MELANOMA SKIN CANCER; MELANOMA STEM CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE; STEM CELL TRANSPLANTATION; STOCHASTIC MODEL; TUMOR GROWTH; TUMOR MODEL;

CELL DIFFERENTIATION; HUMANS; MELANOCYTES; MELANOMA; MODELS, BIOLOGICAL; SKIN NEOPLASMS; STEM CELLS; TISSUE ENGINEERING;

EID: 84874239795     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2012.08.014     Document Type: Article

References (124)

1. Silvers W.K. The coat colors of mice 1972, Springer-Verlag, New York.
2. Nishimura E.K., Jordan S.A., Oshima H., et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002, 416:854-860.
3. Nishimura E.K., Granter S.R., Fisher D.E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 2005, 307:720-724.
4. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
5. Middleton M.R., Grob J.J., Aaronson N., et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000, 18:158-166.
6. Bollag G., Hirth P., Tsai J., et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 2010, 467:596-599.
7. Flaherty K.T., Puzanov I., Kim K.B., et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010, 363:809-819.
8. Davies H., Bignell G.R., Cox C., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
9. Halaban R., Zhang W., Bacchiocchi A., et al. PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells. Pigment Cell Melanoma Res 2010, 23:190-200.
10. Nazarian R., Shi H., Wang Q., et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 2010, 468:973-977.
11. Poulikakos P.I., Zhang C., Bollag G., Shokat K.M., Rosen N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 2010, 464:427-430.
12. Villanueva J., Vultur A., Lee J.T., et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell 2010, 18:683-695.
13. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011, 17:313-319.
14. Lapidot T., Sirard C., Vormoor J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
15. Morrison S.J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441:1068-1074.
16. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
17. Hall P.A., Watt F.M. Stem cells: the generation and maintenance of cellular diversity. Development 1989, 106:619-633.
18. Potten C.S., Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990, 110:1001-1020.
19. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
20. Snippert H.J., Clevers H. Tracking adult stem cells. EMBO Rep 2011, 12:113-122.
21. Arai F., Hirao A., Ohmura M., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118:149-161.
22. Cotsarelis G., Sun T.T., Lavker R.M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990, 61:1329-1337.
23. Potten C.S., Booth C., Pritchard D.M. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 1997, 78:219-243.
24. Wilson A., Laurenti E., Oser G., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129.
25. Barker N., Huch M., Kujala P., et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010, 6:25-36.
26. Barker N., van Es J.H., Kuipers J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
27. Kiel M.J., He S., Ashkenazi R., et al. Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature 2007, 449:238-242.
28. Gilbert P.M., Havenstrite K.L., Magnusson K.E., et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 2010, 329:1078-1081.
29. Jaks V., Barker N., Kasper M., et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet 2008, 40:1291-1299.
30. Jensen K.B., Collins C.A., Nascimento E., et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 2009, 4:427-439.
31. Morris R.J., Liu Y., Marles L., et al. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 2004, 22:411-417.
32. Snippert H.J., Haegebarth A., Kasper M., et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 2010, 327:1385-1389.
33. Blanpain C., Lowry W.E., Geoghegan A., Polak L., Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004, 118:635-648.
34. Ito M., Yang Z., Andl T., et al. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 2007, 447:316-320.
35. Levy V., Lindon C., Zheng Y., Harfe B.D., Morgan B.A. Epidermal stem cells arise from the hair follicle after wounding. FASEB J 2007, 21:1358-1366.
36. Kretzschmar K., Watt F.M. Lineage tracing. Cell 2012, 148:33-45.
37. Feil R., Wagner J., Metzger D., Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 1997, 237:752-757.
38. Chen M.R., Liu S.W., Wu T.C., et al. RU486-inducible recombination in the salivary glands of lactoferrin promoter-driven green fluorescent Cre transgenic mice. Genesis 2010, 48:585-595.
39. Tsujita M., Mori H., Watanabe M., Suzuki M., Miyazaki J., Mishina M. Cerebellar granule cell-specific and inducible expression of Cre recombinase in the mouse. J Neurosci 1999, 19:10318-10323.
40. Nishimura E.K. Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res 2011, 24:401-410.
41. Tu S., Johnson S.L. Clonal analyses reveal roles of organ founding stem cells, melanocyte stem cells and melanoblasts in establishment, growth and regeneration of the adult zebrafish fin. Development 2010, 137:3931-3939.
42. Paus R., Cotsarelis G. The biology of hair follicles. N Engl J Med 1999, 341:491-497.
43. Botchkareva N.V., Botchkarev V.A., Gilchrest B.A. Fate of melanocytes during development of the hair follicle pigmentary unit. J Investig Dermatol Symp Proc 2003, 8:76-79.
44. Muller-Rover S., Handjiski B., van der Veen C., et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001, 117:3-15.
45. Paus R., Muller-Rover S., Van Der Veen C., et al. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999, 113:523-532.
46. Slominski A., Paus R. Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993, 101:90S-97S.
47. Slominski A., Paus R., Plonka P., et al. Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol 1994, 102:862-869.
48. Slominski A., Wortsman J., Plonka P.M., Schallreuter K.U., Paus R., Tobin D.J. Hair follicle pigmentation. J Invest Dermatol 2005, 124:13-21.
49. Mackenzie M.A., Jordan S.A., Budd P.S., Jackson I.J. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev Biol 1997, 192:99-107.
50. Unna P.G. Beiträge zur histologie und entwicklungsgeschichte der menschlichen oberhaut und ihrer anhangsgebilde. Arch Mikroskop Anat entwicklungsmech 1876, 12:665-741.
51. Pasolli H.A. The hair follicle bulge: a niche for adult stem cells. Microsc Microanal 2011, 17:513-519.
52. Nishikawa S., Osawa M. Generating quiescent stem cells. Pigment Cell Res 2007, 20:263-270.
53. Nishikawa S., Kusakabe M., Yoshinaga K., et al. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J 1991, 10:2111-2118.
54. Okura M., Maeda H., Nishikawa S., Mizoguchi M. Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J Invest Dermatol 1995, 105:322-328.
55. Raymond K., Deugnier M.A., Faraldo M.M., Glukhova M.A. Adhesion within the stem cell niches. Curr Opin Cell Biol 2009, 21:623-629.
56. O'Reilly A.M., Lee H.H., Simon M.A. Integrins control the positioning and proliferation of follicle stem cells in the Drosophila ovary. J Cell Biol 2008, 182:801-815.
57. Rabbani P., Takeo M., Chou W., et al. Coordinated activation of Wnt in epithelial and melanocyte stem cells initiates pigmented hair regeneration. Cell 2011, 145:941-955.
58. Lang D., Lu M.M., Huang L., et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 2005, 433:884-887.
59. Kubic J.D., Young K.P., Plummer R.S., Ludvik A.E., Lang D. Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res 2008, 21:627-645.
60. Ikeya M., Lee S.M., Johnson J.E., McMahon A.P., Takada S. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature 1997, 389:966-970.
61. Dorsky R.I., Moon R.T., Raible D.W. Control of neural crest cell fate by the Wnt signalling pathway. Nature 1998, 396:370-373.
62. Tumbar T., Guasch G., Greco V., et al. Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363.
63. Osawa M., Egawa G., Mak S.S., et al. Molecular characterization of melanocyte stem cells in their niche. Development 2005, 132:5589-5599.
64. Nishimura E.K., Suzuki M., Igras V., et al. Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell 2010, 6:130-140.
65. Watabe T., Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 2009, 19:103-115.
66. Foitzik K., Lindner G., Mueller-Roever S., et al. Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J 2000, 14:752-760.
67. Soma T., Dohrmann C.E., Hibino T., Raftery L.A. Profile of transforming growth factor-beta responses during the murine hair cycle. J Invest Dermatol 2003, 121:969-975.
68. Yang G., Li Y., Nishimura E.K., et al. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell 2008, 32:554-563.
69. Wang M.M. Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol 2011, 43:1550-1562.
70. Kumano K., Masuda S., Sata M., et al. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. Pigment Cell Melanoma Res 2008, 21:70-78.
71. Moriyama M., Osawa M., Mak S.S., et al. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol 2006, 173:333-339.
72. Schouwey K., Delmas V., Larue L., et al. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn 2007, 236:282-289.
73. Schouwey K., Larue L., Radtke F., Delmas V., Beermann F. Transgenic expression of Notch in melanocytes demonstrates RBP-Jkappa-dependent signaling. Pigment Cell Melanoma Res 2010, 23:134-136.
74. Tanimura S., Tadokoro Y., Inomata K., et al. Hair follicle stem cells provide a functional niche for melanocyte stem cells. Cell Stem Cell 2011, 8:177-187.
75. Darling T.N., Bauer J.W., Hintner H., Yancey K.B. Generalized atrophic benign epidermolysis bullosa. Adv Dermatol 1997, 13:87-119. [discussion 20].
76. Hintner H., Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 1982, 118:375-384.
77. Masunaga T., Shimizu H., Yee C., et al. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol 1997, 109:200-206.
78. Nishie W., Sawamura D., Goto M., et al. Humanization of autoantigen. Nat Med 2007, 13:378-383.
79. Nishizawa Y., Uematsu J., Owaribe K. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem 1993, 113:493-501.
80. Powell A.M., Sakuma-Oyama Y., Oyama N., Black M.M. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clin Exp Dermatol 2005, 30:682-687.
81. Inomata K., Aoto T., Binh N.T., et al. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell 2009, 137:1088-1099.
82. Clarke M.F., Dick J.E., Dirks P.B., et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344.
83. Quintana E., Shackleton M., Foster H.R., et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010, 18:510-523.
84. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
85. Roesch A., Fukunaga-Kalabis M., Schmidt E.C., et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141:583-594.
86. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-3988.
87. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
88. Dalerba P., Dylla S.J., Park I.K., et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007, 104:10158-10163.
89. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
90. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
91. Fang D., Nguyen T.K., Leishear K., et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65:9328-9337.
92. Schmidt P., Kopecky C., Hombach A., Zigrino P., Mauch C., Abken H. Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc Natl Acad Sci U S A 2011, 108:2474-2479.
93. Schlaak M., Schmidt P., Bangard C., Kurschat P., Mauch C., Abken H. Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. Oncotarget 2012, 3:22-30.
94. Pinc A., Somasundaram R., Wagner C., et al. Targeting CD20 in melanoma patients at high risk of disease recurrence. Mol Ther 2012, 20:1056-1062.
95. Belicchi M., Pisati F., Lopa R., et al. Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 2004, 77:475-486.
96. Shmelkov S.V., St Clair R., Lyden D., Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005, 37:715-719.
97. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951.
98. Singh S.K., Clarke I.D., Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
99. Monzani E., Facchetti F., Galmozzi E., et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007, 43:935-946.
100. Klein W.M., Wu B.P., Zhao S., Wu H., Klein-Szanto A.J., Tahan S.R. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007, 20:102-107.
101. Rappa G., Fodstad O., Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008, 26:3008-3017.
102. Robey R.W., Massey P.R., Amiri-Kordestani L., Bates S.E. ABC transporters: unvalidated therapeutic targets in cancer and the CNS. Anticancer Agents Med Chem 2010, 10:625-633.
103. Robey R.W., Polgar O., Deeken J., To K.W., Bates S.E. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 2007, 26:39-57.
104. Deichmann M., Thome M., Egner U., Hartschuh W., Kurzen H. The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin. J Cutan Pathol 2005, 32:467-473.
105. Schatton T., Murphy G.F., Frank N.Y., et al. Identification of cells initiating human melanomas. Nature 2008, 451:345-349.
106. Frank N.Y., Pendse S.S., Lapchak P.H., et al. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 2003, 278:47156-47165.
107. Frank N.Y., Margaryan A., Huang Y., et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005, 65:4320-4333.
108. Frank N.Y., Schatton T., Kim S., et al. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 2011, 71:1474-1485.
109. Sharma B.K., Manglik V., Elias E.G. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease. J Surg Res 2010, 163:e11-e15.
110. Vasquez-Moctezuma I., Meraz-Rios M.A., Villanueva-Lopez C.G., et al. ATP-binding cassette transporter ABCB5 gene is expressed with variability in malignant melanoma. Actas Dermosifiliogr 2010, 101:341-348.
111. Botelho M.G., Wang X., Arndt-Jovin D.J., Becker D., Jovin T.M. Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein. J Invest Dermatol 2010, 130:1400-1410.
112. Schatton T., Schutte U., Frank N.Y., et al. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res 2010, 70:697-708.
113. Eggermont A.M., Robert C. New drugs in melanoma: it's a whole new world. Eur J Cancer 2012, 47:2150-2157.
114. Stemple D.L., Anderson D.J. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 1992, 71:973-985.
115. Iwamoto S., Odland P.B., Piepkorn M., Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996, 35:725-731.
116. Boiko A.D., Razorenova O.V., van de Rijn M., et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010, 466:133-137.
117. Civenni G., Walter A., Kobert N., et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 2011, 71:3098-3109.
118. Held M.A., Curley D.P., Dankort D., McMahon M., Muthusamy V., Bosenberg M.W. Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res 2010, 70:388-397.
119. Roesch A., Becker B., Meyer S., et al. Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol 2005, 18:1249-1257.
120. Ito M., Hiramatsu H., Kobayashi K., et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182.
121. Mortarini R., Gismondi A., Maggioni A., Santoni A., Herlyn M., Anichini A. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. Cancer Res 1995, 55:4702-4710.
122. Adams J.M., Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones?. Cancer Res 2008, 68:4018-4021.
123. Becker J.C., Houben R., Schrama D., Voigt H., Ugurel S., Reisfeld R.A. Mouse models for melanoma: a personal perspective. Exp Dermatol 2009, 19:157-164.
124. Larue L., Beermann F. Cutaneous melanoma in genetically modified animals. Pigment Cell Res 2007, 20:485-497.